Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit

Rosen Law Firm says investors may seek lead plaintiff status after claims ARS misled them about Neffy insurance coverage with CVS Caremark.

  • The Rosen Law Firm reminds investors of Aardvark Therapeutics, Inc. securities of the October 13, 2026, lead plaintiff deadline for the ongoing securities fraud lawsuit covering February 13, 2025, through May 14, 2026.
  • According to the lawsuit, Aardvark failed to disclose that ARD-101 was less safe than promised, allegedly overstating the company's clinical, regulatory, and commercial prospects during the Class Period.
  • When true details regarding drug safety entered the market, investors suffered damages because defendants' public statements were materially false and misleading at all relevant times.
  • Interested investors may contact Phillip Kim, Esq. at The Rosen Law Firm toll-free at 866-767-3653 or email case@rosenlegal.com to join the class action.
  • Absent class members remain represented by the Court until a class is certified, meaning individuals need not retain counsel or serve as lead plaintiff to share in potential recoveries.
Insights by Ground AI

31 Articles

The DispatchThe Dispatch
+10 Reposted by 10 other sources
Lean Right

WSE Deadline: WSE Investors with Losses in Excess of $100K Have Opportunity to Lead Wise Group plc Securities Fraud Lawsuit Filed by The Rosen Law Firm

NEW YORK, Sept. 6, 2026 /PRNewswire/ -

·Washington, United States
Read Full Article
The Berkshire EagleThe Berkshire Eagle
+7 Reposted by 7 other sources
Center

AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, Sept. 6, 2026 /PRNewswire/ -

The Paintsville HeraldThe Paintsville Herald
+5 Reposted by 5 other sources
Center

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit

NEW YORK, Sept. 6, 2026 /PRNewswire/ -

Williamson HeraldWilliamson Herald
+2 Reposted by 2 other sources
Center

SMPL Investors Have Opportunity to Lead The Simply Good Foods Company Securities Fraud Lawsuit

NEW YORK, Sept. 6, 2026 /PRNewswire/ -

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 74% of the sources are Center
74% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

News-Herald broke the news on Sunday, September 6, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal